AU Stock MarketDetailed Quotes

CYP Cynata Therapeutics Ltd

Watchlist
  • 0.230
  • 0.0000.00%
20min DelayTrading Nov 4 13:38 AET
41.56MMarket Cap-4259P/E (Static)

About Cynata Therapeutics Ltd Company

Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus. There are currently three active clinical trials taking place using Cymerus technology which are attempting to treat osteoarthritis, respiratory distress, and diabetic foot ulcers.

Company Profile

SymbolCYP
Company NameCynata Therapeutics Ltd
Founded2003
MarketASX
Employees2
Fiscal Year Ends06-30
Address100 Cubitt Street Level 3
CityCremorne
CountryAustralia
Zip Code3121
Phone+61 370676940
Websitehttps://www.cynata.com
Share RegistryAUTOMIC REGISTRY SERVICES LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000 (08) 9324 2099

Company Executives

  • Name
  • Position
  • Salary
  • Ross Macdonald
  • Chief Executive Officer,Managing Director
  • --
  • Geoffrey E.D Brooke
  • Non-Executive Director,Non-Executive Chairman
  • --
  • Paul K Wotton
  • Non-Executive Director
  • --
  • Janine Rolfe
  • Non-Executive Director
  • --
  • David Atkins
  • Non-Executive Director
  • --
  • Darryl Maher
  • Non-Executive Director
  • --
  • Stewart James Washer
  • Non-Executive Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data